regulation of biological quality (GO:0065008) | 1.68 | 7 | GPD1L, SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
regulation of transport (GO:0051049) | 2.24 | 7 | GPD1L, SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
biological regulation (GO:0065007) | 0.39 | 7 | GPD1L, SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
single-organism process (GO:0044699) | 0.48 | 7 | GPD1L, SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
regulation of ion transport (GO:0043269) | 3.4 | 7 | GPD1L, SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
regulation of ion transmembrane transport (GO:0034765) | 3.77 | 7 | GPD1L, SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
regulation of localization (GO:0032879) | 1.94 | 7 | GPD1L, SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
regulation of biological process (GO:0050789) | 0.45 | 7 | GPD1L, SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
regulation of transmembrane transport (GO:0034762) | 3.74 | 7 | GPD1L, SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
regulation of membrane potential (GO:0042391) | 3.89 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
cardiac muscle cell action potential involved in contraction (GO:0086002) | 6.47 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, SCN4B |
cardiac muscle cell action potential (GO:0086001) | 6.33 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
regulation of system process (GO:0044057) | 3.53 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
positive regulation of transport (GO:0051050) | 2.9 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
transport (GO:0006810) | 1.51 | 6 | SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
regulation of cation transmembrane transport (GO:1904062) | 4.4 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
regulation of heart contraction (GO:0008016) | 4.35 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, SCN4B |
regulation of metal ion transport (GO:0010959) | 3.94 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
regulation of heart rate (GO:0002027) | 5.29 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, SCN4B |
multicellular organismal process (GO:0032501) | 1.45 | 6 | SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
single-organism cellular process (GO:0044763) | 0.65 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, KCNJ8 |
regulation of multicellular organismal process (GO:0051239) | 1.87 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
positive regulation of biological process (GO:0048518) | 1.2 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
action potential (GO:0001508) | 5.42 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, SCN4B |
regulation of blood circulation (GO:1903522) | 4.05 | 6 | GPD1L, SCN4B, KCNH2, KCNQ1, CAV3, SCN5A |
cellular process (GO:0009987) | 0.26 | 6 | GPD1L, SCN5A, KCNH2, KCNQ1, CAV3, KCNJ8 |
establishment of localization (GO:0051234) | 1.48 | 6 | SCN4B, KCNQ1, KCNH2, CAV3, SCN5A, KCNJ8 |
localization (GO:0051179) | 1.4 | 6 | SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
system process (GO:0003008) | 2.3 | 6 | SCN5A, KCNQ1, KCNH2, CAV3, SCN4B, KCNJ8 |
ventricular cardiac muscle cell action potential (GO:0086005) | 7.02 | 5 | GPD1L, KCNQ1, SCN5A, CAV3, KCNH2 |
muscle contraction (GO:0006936) | 4.37 | 5 | KCNQ1, SCN5A, SCN4B, CAV3, KCNH2 |
transmembrane transport (GO:0055085) | 2.72 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
cation transport (GO:0006812) | 3.11 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
response to stimulus (GO:0050896) | 1.22 | 5 | KCNQ1, SCN5A, KCNJ8, CAV3, KCNH2 |
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.84 | 5 | KCNQ1, SCN4B, SCN5A, CAV3, KCNH2 |
regulation of membrane repolarization (GO:0060306) | 6.4 | 5 | KCNQ1, SCN4B, SCN5A, CAV3, KCNH2 |
regulation of cellular process (GO:0050794) | 0.5 | 5 | GPD1L, KCNH2, SCN5A, CAV3, KCNQ1 |
positive regulation of ion transport (GO:0043270) | 4.36 | 5 | GPD1L, SCN4B, KCNQ1, SCN5A, KCNH2 |
ion transmembrane transport (GO:0034220) | 3.08 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
muscle system process (GO:0003012) | 4.18 | 5 | KCNQ1, SCN4B, SCN5A, CAV3, KCNH2 |
regulation of cardiac muscle cell membrane repolarization (GO:0099623) | 6.68 | 5 | KCNQ1, SCN4B, SCN5A, CAV3, KCNH2 |
metal ion transport (GO:0030001) | 3.36 | 5 | KCNJ8, SCN4B, KCNQ1, SCN5A, KCNH2 |
inorganic cation transmembrane transport (GO:0098662) | 3.55 | 5 | KCNJ8, SCN4B, KCNQ1, SCN5A, KCNH2 |
inorganic ion transmembrane transport (GO:0098660) | 3.38 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
ion transport (GO:0006811) | 2.66 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
cation transmembrane transport (GO:0098655) | 3.43 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
monovalent inorganic cation transport (GO:0015672) | 3.74 | 5 | KCNQ1, KCNJ8, SCN4B, SCN5A, KCNH2 |
developmental process (GO:0032502) | 1.36 | 4 | KCNQ1, SCN5A, KCNJ8, CAV3 |
regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 4 | GPD1L, KCNQ1, SCN4B, CAV3 |
striated muscle contraction (GO:0006941) | 5.37 | 4 | KCNQ1, SCN4B, SCN5A, KCNH2 |
signaling (GO:0023052) | 3.25 | 4 | KCNQ1, SCN5A, SCN4B, KCNH2 |
cardiac muscle contraction (GO:0060048) | 5.88 | 4 | KCNQ1, SCN4B, SCN5A, KCNH2 |
multicellular organismal signaling (GO:0035637) | 5.36 | 4 | KCNQ1, SCN5A, SCN4B, KCNH2 |
organic substance metabolic process (GO:0071704) | 0.63 | 4 | GPD1L, KCNH2, KCNQ1, CAV3 |
regulation of transporter activity (GO:0032409) | 4.45 | 4 | GPD1L, KCNQ1, SCN4B, CAV3 |
negative regulation of biological process (GO:0048519) | 1.33 | 4 | GPD1L, KCNQ1, KCNH2, CAV3 |
regulation of molecular function (GO:0065009) | 1.78 | 4 | GPD1L, KCNQ1, SCN4B, CAV3 |
regulation of sodium ion transport (GO:0002028) | 5.4 | 4 | GPD1L, SCN5A, SCN4B, CAV3 |
regulation of sodium ion transmembrane transport (GO:1902305) | 5.86 | 4 | GPD1L, SCN5A, SCN4B, CAV3 |
cardiac conduction (GO:0061337) | 5.54 | 4 | KCNQ1, SCN5A, SCN4B, KCNH2 |
single organism signaling (GO:0044700) | 3.25 | 4 | KCNQ1, SCN4B, SCN5A, KCNH2 |
single-organism developmental process (GO:0044767) | 1.49 | 4 | KCNQ1, SCN5A, KCNJ8, CAV3 |
single-organism transport (GO:0044765) | 2.18 | 4 | KCNQ1, KCNH2, KCNJ8, CAV3 |
metabolic process (GO:0008152) | 0.58 | 4 | GPD1L, KCNQ1, KCNH2, CAV3 |
response to chemical (GO:0042221) | 1.98 | 4 | KCNQ1, SCN5A, KCNJ8, KCNH2 |
single-organism localization (GO:1902578) | 2.09 | 4 | KCNQ1, KCNH2, KCNJ8, CAV3 |
primary metabolic process (GO:0044238) | 0.69 | 4 | GPD1L, KCNQ1, KCNH2, CAV3 |
single-multicellular organism process (GO:0044707) | 1.78 | 4 | KCNQ1, SCN5A, SCN4B, KCNH2 |
regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 4 | GPD1L, KCNQ1, SCN4B, CAV3 |
anatomical structure development (GO:0048856) | 1.58 | 4 | KCNQ1, KCNJ8, SCN5A, CAV3 |
cellular metabolic process (GO:0044237) | 0.69 | 4 | GPD1L, KCNH2, KCNQ1, CAV3 |
regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 4 | KCNQ1, SCN4B, SCN5A, KCNH2 |
negative regulation of cellular process (GO:0048523) | 1.41 | 4 | GPD1L, KCNH2, KCNQ1, CAV3 |
positive regulation of cellular process (GO:0048522) | 1.3 | 4 | KCNQ1, KCNH2, SCN5A, CAV3 |
negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | GPD1L, KCNQ1, CAV3 |
regulation of metabolic process (GO:0019222) | 1.02 | 3 | GPD1L, KCNQ1, CAV3 |
regulation of response to stimulus (GO:0048583) | 1.54 | 3 | GPD1L, KCNQ1, CAV3 |
regulation of homeostatic process (GO:0032844) | 3.65 | 3 | GPD1L, SCN5A, CAV3 |
negative regulation of potassium ion transport (GO:0043267) | 6.26 | 3 | KCNH2, KCNQ1, CAV3 |
regulation of potassium ion transport (GO:0043266) | 5.31 | 3 | KCNH2, KCNQ1, CAV3 |
membrane depolarization (GO:0051899) | 5.62 | 3 | SCN4B, SCN5A, KCNH2 |
regulation of striated muscle contraction (GO:0006942) | 5.38 | 3 | KCNQ1, SCN5A, CAV3 |
cellular response to chemical stimulus (GO:0070887) | 2.57 | 3 | KCNQ1, SCN5A, KCNH2 |
negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 3 | KCNQ1, KCNH2, CAV3 |
negative regulation of transmembrane transport (GO:0034763) | 5.38 | 3 | KCNH2, KCNQ1, CAV3 |
single-organism metabolic process (GO:0044710) | 1.63 | 3 | GPD1L, KCNH2, CAV3 |
negative regulation of macromolecule metabolic process (GO:0010605) | 2.01 | 3 | GPD1L, KCNQ1, CAV3 |
cellular potassium ion transport (GO:0071804) | 4.79 | 3 | KCNQ1, KCNJ8, KCNH2 |
potassium ion transmembrane transport (GO:0071805) | 4.79 | 3 | KCNQ1, KCNH2, KCNJ8 |
regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 3 | GPD1L, KCNQ1, CAV3 |
regulation of sodium ion transmembrane transporter activity (GO:2000649) | 6.09 | 3 | GPD1L, SCN4B, CAV3 |
negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.68 | 3 | KCNH2, KCNQ1, CAV3 |
positive regulation of sodium ion transport (GO:0010765) | 6.23 | 3 | GPD1L, SCN5A, SCN4B |
negative regulation of transport (GO:0051051) | 3.6 | 3 | KCNH2, KCNQ1, CAV3 |
regulation of muscle contraction (GO:0006937) | 4.75 | 3 | KCNQ1, SCN5A, CAV3 |
potassium ion transport (GO:0006813) | 4.68 | 3 | KCNQ1, KCNH2, KCNJ8 |
cellular response to stimulus (GO:0051716) | 1.97 | 3 | KCNQ1, KCNH2, SCN5A |
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373) | 7.78 | 3 | GPD1L, SCN5A, CAV3 |
negative regulation of ion transport (GO:0043271) | 4.94 | 3 | KCNQ1, KCNH2, CAV3 |
regulation of potassium ion transmembrane transport (GO:1901379) | 5.62 | 3 | KCNQ1, KCNH2, CAV3 |
regulation of muscle system process (GO:0090257) | 4.51 | 3 | KCNQ1, SCN5A, CAV3 |
membrane depolarization during action potential (GO:0086010) | 6.07 | 3 | SCN5A, SCN4B, KCNH2 |
regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 3 | KCNQ1, SCN5A, CAV3 |
negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 3 | KCNH2, KCNQ1, CAV3 |
regulation of membrane depolarization (GO:0003254) | 6.04 | 3 | GPD1L, SCN5A, CAV3 |
regulation of ion homeostasis (GO:2000021) | 4.44 | 3 | GPD1L, SCN5A, CAV3 |
regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | GPD1L, CAV3 |
regulation of primary metabolic process (GO:0080090) | 1.08 | 2 | GPD1L, CAV3 |
negative regulation of response to stimulus (GO:0048585) | 2.52 | 2 | GPD1L, CAV3 |
cation homeostasis (GO:0055080) | 3.46 | 2 | KCNH2, CAV3 |
inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | KCNH2, CAV3 |
positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 2 | KCNH2, KCNQ1 |
membrane repolarization during action potential (GO:0086011) | 7.43 | 2 | KCNQ1, KCNH2 |
organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | GPD1L, KCNQ1 |
potassium ion export (GO:0071435) | 7.43 | 2 | KCNQ1, KCNH2 |
negative regulation of signal transduction (GO:0009968) | 2.75 | 2 | GPD1L, CAV3 |
regulation of signal transduction (GO:0009966) | 1.84 | 2 | GPD1L, CAV3 |
animal organ development (GO:0048513) | 2.53 | 2 | KCNJ8, CAV3 |
regulation of action potential (GO:0098900) | 6.07 | 2 | SCN5A, CAV3 |
negative regulation of molecular function (GO:0044092) | 2.74 | 2 | KCNQ1, CAV3 |
ion homeostasis (GO:0050801) | 3.42 | 2 | KCNH2, CAV3 |
regulation of cell proliferation (GO:0042127) | 2.41 | 2 | SCN5A, CAV3 |
glycerolipid metabolic process (GO:0046486) | 3.91 | 2 | GPD1L, CAV3 |
response to organic substance (GO:0010033) | 2.2 | 2 | KCNQ1, KCNJ8 |
heterocycle metabolic process (GO:0046483) | 1.31 | 2 | GPD1L, KCNQ1 |
regulation of phosphorylation (GO:0042325) | 2.5 | 2 | GPD1L, CAV3 |
negative regulation of phosphorylation (GO:0042326) | 3.7 | 2 | GPD1L, CAV3 |
response to external stimulus (GO:0009605) | 2.55 | 2 | KCNJ8, CAV3 |
chemical homeostasis (GO:0048878) | 2.97 | 2 | KCNH2, CAV3 |
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915) | 8.34 | 2 | KCNH2, KCNQ1 |
positive regulation of heart contraction (GO:0045823) | 6.15 | 2 | KCNQ1, SCN5A |
regulation of protein localization to cell surface (GO:2000008) | 6.43 | 2 | GPD1L, CAV3 |
negative regulation of transporter activity (GO:0032410) | 5.59 | 2 | KCNQ1, CAV3 |
negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 2 | KCNQ1, CAV3 |
positive regulation of transmembrane transport (GO:0034764) | 4.99 | 2 | KCNQ1, KCNH2 |
nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | GPD1L, KCNQ1 |
cellular macromolecule metabolic process (GO:0044260) | 0.93 | 2 | KCNH2, CAV3 |
regulation of anatomical structure size (GO:0090066) | 3.78 | 2 | KCNJ8, CAV3 |
lipid metabolic process (GO:0006629) | 2.68 | 2 | GPD1L, CAV3 |
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372) | 7.94 | 2 | KCNQ1, SCN5A |
sodium ion transport (GO:0006814) | 4.75 | 2 | SCN5A, SCN4B |
positive regulation of blood circulation (GO:1903524) | 5.16 | 2 | KCNQ1, SCN5A |
negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 2 | GPD1L, CAV3 |
regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 2 | SCN5A, SCN4B |
regulation of intracellular signal transduction (GO:1902531) | 2.31 | 2 | GPD1L, CAV3 |
potassium ion export across plasma membrane (GO:0097623) | 9.04 | 2 | KCNH2, KCNQ1 |
response to nitrogen compound (GO:1901698) | 3.12 | 2 | KCNQ1, KCNJ8 |
cardiac muscle cell membrane repolarization (GO:0099622) | 7.43 | 2 | KCNH2, KCNQ1 |
ventricular cardiac muscle cell membrane repolarization (GO:0099625) | 8.34 | 2 | KCNQ1, KCNH2 |
acylglycerol metabolic process (GO:0006639) | 5.27 | 2 | GPD1L, CAV3 |
neutral lipid metabolic process (GO:0006638) | 5.26 | 2 | GPD1L, CAV3 |
regulation of cellular protein localization (GO:1903827) | 3.43 | 2 | GPD1L, CAV3 |
negative regulation of signaling (GO:0023057) | 2.65 | 2 | GPD1L, CAV3 |
cellular nitrogen compound metabolic process (GO:0034641) | 1.22 | 2 | GPD1L, KCNQ1 |
negative regulation of cell communication (GO:0010648) | 2.66 | 2 | GPD1L, CAV3 |
regulation of signaling (GO:0023051) | 1.72 | 2 | GPD1L, CAV3 |
regulation of cell communication (GO:0010646) | 1.73 | 2 | GPD1L, CAV3 |
response to organic cyclic compound (GO:0014070) | 3.07 | 2 | KCNQ1, KCNJ8 |
regulation of protein localization (GO:0032880) | 2.88 | 2 | GPD1L, CAV3 |
nucleobase-containing compound metabolic process (GO:0006139) | 1.35 | 2 | GPD1L, KCNQ1 |
negative regulation of protein metabolic process (GO:0051248) | 2.82 | 2 | GPD1L, CAV3 |
positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 2 | KCNQ1, SCN5A |
negative regulation of phosphorus metabolic process (GO:0010563) | 3.45 | 2 | GPD1L, CAV3 |
regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | GPD1L, CAV3 |
membrane repolarization (GO:0086009) | 7.02 | 2 | KCNH2, KCNQ1 |
regulation of protein modification process (GO:0031399) | 2.32 | 2 | GPD1L, CAV3 |
positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | SCN5A, CAV3 |
triglyceride metabolic process (GO:0006641) | 5.41 | 2 | GPD1L, CAV3 |
regulation of actin filament-based process (GO:0032970) | 3.97 | 2 | SCN5A, CAV3 |
cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | GPD1L, KCNQ1 |
membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 7.43 | 2 | KCNH2, KCNQ1 |
membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 7.09 | 2 | SCN5A, SCN4B |
cellular lipid metabolic process (GO:0044255) | 2.92 | 2 | GPD1L, CAV3 |
AV node cell action potential (GO:0086016) | 8.34 | 2 | SCN5A, SCN4B |
negative regulation of cellular protein metabolic process (GO:0032269) | 2.88 | 2 | GPD1L, CAV3 |
regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | GPD1L, CAV3 |
positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 2 | KCNH2, KCNQ1 |
response to drug (GO:0042493) | 3.71 | 2 | KCNQ1, KCNH2 |
macromolecule metabolic process (GO:0043170) | 0.83 | 2 | KCNH2, CAV3 |
negative regulation of protein modification process (GO:0031400) | 3.4 | 2 | GPD1L, CAV3 |
regulation of cellular localization (GO:0060341) | 3.03 | 2 | GPD1L, CAV3 |
negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | GPD1L, CAV3 |
regulation of cellular metabolic process (GO:0031323) | 1.07 | 2 | GPD1L, CAV3 |
homeostatic process (GO:0042592) | 2.61 | 2 | KCNH2, CAV3 |
cellular response to drug (GO:0035690) | 5.48 | 2 | KCNH2, KCNQ1 |
positive regulation of potassium ion transport (GO:0043268) | 6.09 | 2 | KCNQ1, KCNH2 |
sodium ion transmembrane transport (GO:0035725) | 5.23 | 2 | SCN5A, SCN4B |
positive regulation of heart rate (GO:0010460) | 6.59 | 2 | KCNQ1, SCN5A |
positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.43 | 2 | KCNQ1, KCNH2 |
negative regulation of phosphate metabolic process (GO:0045936) | 3.45 | 2 | GPD1L, CAV3 |
regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | GPD1L, CAV3 |
metal ion homeostasis (GO:0055065) | 3.61 | 2 | KCNH2, CAV3 |
regulation of response to stress (GO:0080134) | 2.53 | 2 | KCNQ1, CAV3 |
response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | KCNQ1, KCNJ8 |
response to abiotic stimulus (GO:0009628) | 2.8 | 2 | KCNJ8, CAV3 |
regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.02 | 2 | KCNQ1, CAV3 |
negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.96 | 2 | KCNQ1, CAV3 |
phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 2 | GPD1L, KCNH2 |
phosphorus metabolic process (GO:0006793) | 2.15 | 2 | GPD1L, KCNH2 |
negative regulation of protein phosphorylation (GO:0001933) | 3.79 | 2 | GPD1L, CAV3 |
regulation of protein phosphorylation (GO:0001932) | 2.57 | 2 | GPD1L, CAV3 |